Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (96)
Aldeyra Therapeutics, Inc. (ALDX)
DOUGLAS RICHARD — Director
Shares
70,000
Price
$1.40
Total Value
$98.00K
Shares Held After
195,000
% of Holdings
35.9%
Aldeyra Therapeutics, Inc. (ALDX)
Alfieri Michael — Principal Financial Officer
Shares
5,000
Price
$1.42
Total Value
$7.10K
Shares Held After
7,500
% of Holdings
66.7%
Tonix Pharmaceuticals Holding Corp. (TNXP)
LEDERMAN SETH — Director
Shares
15,000
Price
$14.89
Total Value
$223.35K
Shares Held After
15,001
% of Holdings
100.0%
CORCEPT THERAPEUTICS INC (CORT)
BAKER G LEONARD JR — Director
Shares
24,218
Price
$33.56
Total Value
$812.84K
Shares Held After
1,146,631
% of Holdings
2.1%
CORCEPT THERAPEUTICS INC (CORT)
BAKER G LEONARD JR — Director
Shares
75,782
Price
$33.00
Total Value
$2.50M
Shares Held After
1,122,413
% of Holdings
6.8%
Zai Lab Ltd (ZLAB)
GAYNOR RICHARD — Director
Shares
1,731
Price
$18.91
Total Value
$32.73K
Shares Held After
56,630
% of Holdings
3.1%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
595
Price
$24.99
Total Value
$14.87K
Shares Held After
675,610
% of Holdings
0.1%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
595
Price
$24.99
Total Value
$14.87K
Shares Held After
675,613
% of Holdings
0.1%
EyePoint, Inc. (EYPT)
Duker Jay S. — Director
Shares
1,500
Price
$13.15
Total Value
$19.72K
Shares Held After
100,665
% of Holdings
1.5%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
17,716
Price
$24.88
Total Value
$440.72K
Shares Held After
675,015
% of Holdings
2.6%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
17,717
Price
$24.88
Total Value
$440.74K
Shares Held After
675,018
% of Holdings
2.6%
Orchestra BioMed Holdings, Inc. (OBIO)
Hochman David P — Director
Shares
10,000
Price
$4.29
Total Value
$42.90K
Shares Held After
1,086,467
% of Holdings
0.9%
MBX Biosciences, Inc. (MBX)
Hawryluk P. Kent — Director
Shares
18,500
Price
$28.41
Total Value
$525.66K
Shares Held After
486,777
% of Holdings
3.8%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
6,187
Price
$24.99
Total Value
$154.58K
Shares Held After
657,299
% of Holdings
0.9%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
6,187
Price
$24.99
Total Value
$154.58K
Shares Held After
657,301
% of Holdings
0.9%
Absci Corp (ABSI)
Busch Andreas — Chief Innovation Officer
Shares
100,000
Price
$2.29
Total Value
$229.00K
Shares Held After
421,446
% of Holdings
23.7%
ONCOLYTICS BIOTECH INC (ONCY)
Kelly Jared — Director
Shares
5,050
Price
$0.96
Total Value
$4.85K
Shares Held After
114,050
% of Holdings
4.4%
Lineage Cell Therapeutics, Inc. (LCTX)
Culley Brian M — Director
Shares
15,000
Price
$1.62
Total Value
$24.38K
Shares Held After
255,516
% of Holdings
5.9%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
2,000
Price
$19.35
Total Value
$38.70K
Shares Held After
13,500
% of Holdings
14.8%
ONCOLYTICS BIOTECH INC (ONCY)
Parsons James T. — Director
Shares
10,000
Price
$1.03
Total Value
$10.30K
Shares Held After
41,849
% of Holdings
23.9%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$21.55
Total Value
$21.55K
Shares Held After
38,415
% of Holdings
2.6%
Korro Bio, Inc. (KRRO)
BASKETT FOREST — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Korro Bio, Inc. (KRRO)
Chang Carmen — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Korro Bio, Inc. (KRRO)
Florence Anthony A. Jr. — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Korro Bio, Inc. (KRRO)
Yang Rick — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Korro Bio, Inc. (KRRO)
New Enterprise Associates 17, L.P. — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Korro Bio, Inc. (KRRO)
SANDELL SCOTT D — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Korro Bio, Inc. (KRRO)
Mathers Edward T — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Annexon, Inc. (ANNX)
Carson William H. — Director
Shares
8,000
Price
$5.67
Total Value
$45.36K
Shares Held After
62,405
% of Holdings
12.8%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$22.12
Total Value
$22.12K
Shares Held After
37,415
% of Holdings
2.7%
MANNKIND CORP (MNKD)
Castagna Michael — Director
Shares
100,000
Price
$2.59
Total Value
$259.00K
Shares Held After
2,575,911
% of Holdings
3.9%
Viking Therapeutics, Inc. (VKTX)
Aubuchon Neil William — Chief Commercial Officer
Shares
4,475
Price
$33.50
Total Value
$149.91K
Shares Held After
4,475
% of Holdings
100.0%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
1,000
Price
$6.60
Total Value
$6.60K
Shares Held After
628,813
% of Holdings
0.2%
Keros Therapeutics, Inc. (KROS)
BIENAIME JEAN JACQUES — Director
Shares
2,000
Price
$11.21
Total Value
$22.42K
Shares Held After
7,450
% of Holdings
26.8%
Entera Bio Ltd. (ENTX)
Germano Geno J — Director
Shares
20,000
Price
$1.30
Total Value
$26.00K
Shares Held After
40,000
% of Holdings
50.0%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
3,000
Price
$15.06
Total Value
$45.18K
Shares Held After
11,500
% of Holdings
26.1%
Lyell Immunopharma, Inc. (LYEL)
ARCH Venture Partners IX, LLC — 10% Owner
Shares
488,090
Price
$25.61
Total Value
$12.50M
Shares Held After
1,426,528
% of Holdings
34.2%
Lyell Immunopharma, Inc. (LYEL)
ARCH Venture Fund XIII, L.P. — 10% Owner
Shares
488,090
Price
$25.61
Total Value
$12.50M
Shares Held After
1,426,528
% of Holdings
34.2%
ARVINAS, INC. (ARVN)
Morrison Briggs — Director
Shares
20,000
Price
$13.40
Total Value
$268.07K
Shares Held After
96,021
% of Holdings
20.8%
Altimmune, Inc. (ALT)
Durso Jerome Benedict — Director
Shares
20,000
Price
$3.54
Total Value
$70.79K
Shares Held After
32,500
% of Holdings
61.5%
Altimmune, Inc. (ALT)
WEAVER GREGORY L — Chief Financial Officer
Shares
5,000
Price
$3.54
Total Value
$17.70K
Shares Held After
28,078
% of Holdings
17.8%
ADMA BIOLOGICS, INC. (ADMA)
ELMS STEVE — Director
Shares
7,000
Price
$15.39
Total Value
$107.73K
Shares Held After
2,045,730
% of Holdings
0.3%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
10,000
Price
$3.90
Total Value
$39.00K
Shares Held After
402,702
% of Holdings
2.5%
Quantum-Si Inc (QSI)
Kummeth Charles R. — Director
Shares
500,000
Price
$0.92
Total Value
$459.80K
Shares Held After
855,000
% of Holdings
58.5%
Quantum-Si Inc (QSI)
Dowdy Paula — Director
Shares
109,890
Price
$0.95
Total Value
$104.45K
Shares Held After
269,107
% of Holdings
40.8%
Entera Bio Ltd. (ENTX)
Ellis Sean — Director
Shares
10,000
Price
$1.23
Total Value
$12.30K
Shares Held After
188,098
% of Holdings
5.3%
ADMA BIOLOGICS, INC. (ADMA)
ELMS STEVE — Director
Shares
7,000
Price
$15.67
Total Value
$109.69K
Shares Held After
2,038,730
% of Holdings
0.3%
ProMIS Neurosciences Inc. (PMN)
Williams Eugene — Director
Shares
2,000
Price
$24.40
Total Value
$48.80K
Shares Held After
12,397
% of Holdings
16.1%
ProMIS Neurosciences Inc. (PMN)
Williams Eugene — Director
Shares
2,000
Price
$24.00
Total Value
$48.00K
Shares Held After
10,397
% of Holdings
19.2%
FibroBiologics, Inc. (FBLG)
O'HEERON PETE — Director
Shares
15,872
Price
$0.38
Total Value
$6.01K
Shares Held After
5,958,147
% of Holdings
0.3%
Showing 1–50 of 96 transactions (page 1 of 2)